Mr. Edgar Montero reports

CHEMESIS INTERNATIONAL INC. & RAPID DOSE THERAPEUTICS SIGN AGREEMENT TO BRING QUICKSTRIP ORAL THIN STRIPS TO MICHIGAN

Chemesis International Inc. and Rapid Dose Therapeutics Inc. have signed an additional definitive agreement to bring QuickStrip oral thin strips to the state of Michigan. The company previously announced a definitive agreement to produce QuickStrips for the state of California and subsequently to bring QuickStrips to Puerto Rico.

"We are focused and committed to providing consumers in the U.S. medical and recreational cannabis markets a Smoke-Free Choice," said Mark Upsdell, chief executive officer of RDT. "RDT will continue to expand our strategic global partnerships and further strengthen our market share in the cannabis sector. This agreement with Chemesis improves the QuickStrip position as a growing international brand and delivery device to Michigan consumers, while simultaneously offering health benefits and improving patient outcomes."

RDT's proprietary QuickStrip technology is a Quick, Convenient, Precise, Discreet oral fast-dissolving drug delivery system that offers a No Smoke, No Smell, No Stigma product to consumers. Chemesis expects to produce and distribute QuickStrip in Michigan by the end of 2019.

"Chemesis continues to have an incredible partnership with RDT, we are extremely excited to bring QuickStrip oral thin strips to another state," said chief executive officer of Chemesis Edgar Montero. "Chemesis has recently announced the commercialization of QuickStrip oral thin strips in Puerto Rico, a significant step forward to bringing large-scale distribution across the United States and other markets. Chemesis believes its partnership with RDT will continue to bring value to its shareholders."

As part of the agreement, Chemesis maintains the option to add future markets as the opportunity in those regions evolve.

About Chemesis International Inc.

Chemesis International is a vertically integrated U.S. multistate operator with international operations in Puerto Rico and Colombia.

The company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The company operates a portfolio of brands which cater to a wide community of cannabis consumers, with focus on quality and consistency.

Chemesis has facilities in both Puerto Rico and California, and is in the process of constructing a good-manufacturing-practices-certified facility in Colombia.

We seek Safe Harbor.